China Medical System: New Drug Application for Vitiligo Indication of Ruxolitinib Phosphate Cream Accepted in China China Medical System Holdings Ltd. Sep 24, 2024 22:00 JST Read More
Rozebalamin(R) for Injection 25 mg (Mecobalamin) Approved in Japan for Amyotrophic Lateral Sclerosis Eisai Sep 24, 2024 15:06 HKT/SGT Read More
Anticancer Agent "Tasfygo(R) Tablets 35mg" (Tasurgratinib Succinate) Approved in Japan for Biliary Tract Cancer with FGFR2 Gene Fusions or Rearrangements Eisai Sep 24, 2024 14:01 HKT/SGT Read More
Olympus Launches New 4K Camera Head for Urological Endoscopy Olympus Sep 20, 2024 14:00 HKT/SGT Read More
Ainos、治療法が限られている希少疾患であるシェーグレン症候群の治療薬VELDONAの台湾での臨床試験開始計画を発表 Ainos, Inc Sep 19, 2024 21:00 JST Read More
Cordlife Unveils Enhanced Processing and Storage Facility in Singapore; Strengthens Processes as It Resumes Collection of Cord Blood Units in a Controlled Manner Cordlife Group Limited Sep 17, 2024 13:30 HKT/SGT Read More
LENVIMA(R) (lenvatinib) Plus KEYTRUDA(R) (pembrolizumab) in Combination With Transarterial Chemoembolization (TACE) Significantly Improved Progression-Free Survival Compared to TACE Alone in Patients With Unresectable, Non-Metastatic Hepatocellular Carcinoma (HCC) Eisai Sep 17, 2024 09:08 HKT/SGT Read More
Femto Technologies Regains Compliance With Nasdaq Minimum Bid Price Requirement Femto Technologies Inc Sep 12, 2024 21:00 HKT/SGT Read More
Eisai Accelerates Progress in Oncology Research with New Data at ESMO Congress 2024 Eisai Sep 05, 2024 15:59 HKT/SGT Read More
Eisai Announces Status Relating to Acquisition of Own Shares Eisai Sep 02, 2024 14:12 HKT/SGT Read More
Hitachi High-Tech and Gencurix entered a partnership in cancer molecular diagnostics business Hitachi, Ltd. Aug 28, 2024 17:44 HKT/SGT Read More
Fujitsu tackles 'drug loss' in Japan through ecosystem to accelerate digitalization of clinical trials Fujitsu Ltd Aug 26, 2024 11:19 HKT/SGT Read More
Hitachi High-Tech Launches New Tabletop Microscopes with Enhanced Usability: TM4000PlusIII and TM4000III Hitachi, Ltd. Aug 22, 2024 21:30 HKT/SGT Read More
Leqembi (lecanemab) Authorized for Early Alzheimer's Disease in Great Britain Eisai Aug 22, 2024 18:54 HKT/SGT Read More
China Medical System (00867) Released its 2024 Interim Results: Steady Increase in Revenue and Profit Compared with 2H 2023 China Medical System Holdings Ltd. Aug 16, 2024 14:00 JST Read More
"LEQEMBI" (Lecanemab) Approved for the Treatment of Alzheimer's Disease in the United Arab Emirates Eisai Aug 14, 2024 08:59 HKT/SGT Read More
NEC Bio Therapeutics and AGC Biologics Announce Collaboration to Manufacture Personalized Cancer Vaccines NEC Corporation Aug 08, 2024 10:12 HKT/SGT Read More
Eisai: Update Regarding the Regulatory Status of LEQEMBI Subcutaneous Formulation Eisai Aug 06, 2024 12:15 HKT/SGT Read More
